RegWardenFDA facility compliance records
Facility

ACTIM OY

1 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2023: 1 recalls20172018201920202021202212023202420252026
  • Recalls (1)

Devices registered here (1)

  • Immunoassay, Insulin-Like Growth Factor Binding Protein-1
    Product code OAM (opens in a new tab) · Class I · Clinical Chemistry · 21 CFR 862.1550

Recalls & enforcement

  • Class IIOngoing2023-11-23
    Interference testing has shown that the presence of personal lubricants in the vaginal specimen can interfere with the PROM test result by providing a false positive result.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “ACTIM OY (FEI 1000212994) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1000212994-actim-oy/

Not open yet

Alerts for ACTIM OY

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.